2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$11.47$0.00 (0.00%)
Price as of Jun 23, 2026 7:03 PM EDT- $1.5BMarket Cap
- 58.64%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$11.47$0.00 (0.00%)
NEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.47 | ||
Change | +$0.27 (+2.41%) | ||
Open | $11.14 | ||
High | $11.68 | ||
Low | $11.13 | ||
Previous Close | $11.20 | ||
Volume | 3,521,948 | ||
30-Day Average Volume | 2,776,765 | ||
1-Week Change | 9.34% | ||
1-Month Change | 24.27% | ||
1-Year Change | 58.64% | ||
3-Year Change | -31.19% | ||
5-Year Change | -74.45% | ||
Fundamentals | |||
Shares Outstanding | 130.2M | ||
Total Assets | $1.3B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $186.7M | ||
Net Income | -$17.1M | ||
Free Cash Flow | -$13.1M | ||
EBIT | -$17.6M | ||
EBITDA | -$9.9M | ||
Net Working Capital | $289.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -166 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -179 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue